[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (3): 270-273.doi: 10.3736/jcim20080310

• Original Experimental Research • Previous Articles     Next Articles

Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells

Hai-bo Yu1(), Cheng-en Pan1, Wu-jun Wu1, Si-hai Zhao2, Hui-feng Zhang3   

  1. 1. Department of Hepatobiliary Surgery, the First Affiliated Hospital, Medical School of Xi'an Jiao tong University, Xi’an, Shaanxi Province 710061, China;
    2. Department of Immunology and Microbiology, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi Province 710061, China
    3. Intensive Care and Treatment Center, Henan Provincial People's Hospital, Zhengzhou, Henan Province 450003, China
  • Received:2007-05-18 Online:2008-03-20 Published:2008-03-15
  • Contact: HB Yu E-mail:yhb2101661@sohu.com

RichHTML

1

PDF (PC)

60

Like

Objective: To observe the effects of resveratrol on proliferation of human hepatocellular carcinoma cell line SMMC-7721 cells and expression of matrix metalloproteinase-9 (MMP-9) in vitro.Methods: SMMC-7721 cells were treated with different concentrations of resveratrol for 24, 48 and 72 h, respectively. The effect of resveratrol on proliferation of SMMC-7721 cells was assessed with methyl thiazolyl tetrazolium (MTT). The expression of MMP-9 mRNA was determined by reverse transcription polymerase chain reaction (RT-PCR). MMP-9 protein was identified by Western blot analysis.Results: Resveratrol could inhibit the proliferation of SMMC-7721 cells with dose- and time-dependent effects. Moreover, both MMP-9 mRNA expression and MMP-9 protein production were markedly reduced after resveratrol treatment.Conclusion: Resveratrol can inhibit the proliferation of SMMC-7721 cells and down-regulate MMP-9 expression. It is presumed that resveratrol may suppress the invasion and metastasis of hepatocellular carcinoma.

Key words: resveratrol, liver cancer, matrix metalloproteinase-9

CLC Number: 

  • R735.7

Table 1

Growth-inhibition of resveratrol on human hepatocellular carcinoma cell line SMMC-7721 ($\bar{x}$±s, %)"

Concentration of Res n Growth-inhibiting rate at different action time
24 h 48 h 72 h
10 μmol/L 4 2.1±1.2 2.9±1.9 4.9±3.7
50 μmol/L 4 10.0±5.7 12.6±3.6 15.7±4.2
100 μmol/L 4 14.0±4.8 18.2±4.3 29.9±14.5
200 μmol/L 4 27.5±3.6 37.7±5.1 45.0±18.1
500 μmol/L 4 57.5±2.3 67.8±2.9 79.0±1.3

Figure 1

Inhibition of Res on expression of MMP-9 mRNA in SMMC-7721 cells A: MMP-9 mRNA expression under different concentrations of Res treatment for 24 h; B: Relative content of MMP-9 mRNA level."

Figure 2

Inhibition of Res on MMP-9 protein expression in SMMC-7721 cells A: MMP-9 protein expression under different concentrations of Res treatment for 24 h; B: Relative content of MMP-9 protein level."

[1] Huynh H . Overexpression of tumour suppressor retinoblastoma 2 protein(pRb2/p130) in hepatocellular carcinoma[J]. Carcinogenesis, 2004,25(8):1485-1494
doi: 10.1093/carcin/bgh154
[2] Jang M, Cai L, Udeani GO , et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes[J]. Science, 1997,275(5297):218-220
doi: 10.1126/science.275.5297.218 pmid: 8985016
[3] Yokota J . Tumor progression and metastasis[J]. Carcinogenesis, 2000,21(3):497-503
doi: 10.1093/carcin/21.3.497
[4] Sakamoto Y, Mafune K, Mori M , et al. Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma[J]. Int J Oncol, 2000,17(2):237-243
doi: 10.3892/ijo.17.2.237 pmid: 10891530
[5] Zhong C, Guo RP, Shi M , et al. Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma[J]. Ai Zheng, 2006,25(5):599-603
钟崇, 郭荣平, 石明 . VEGF和MMP-9在肝癌组织中的表达及其临床意义[J]. 癌症, 2006,25(5):599-603
[6] Fu ZD, Cao Y, Wang KF , et al. Chemopreventive effect of resveratrol to cancer[J]. Ai Zheng, 2004,23(8):869-873
付招娣, 曹玉, 王凯风 . 白藜芦醇对癌的化学预防作用[J]. 癌症, 2004,23(8):869-873
[7] Ahmad N, Adhami VM, Afaq F , et al. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells[J]. Clin Cancer Res, 2001,7(5):1466-1473
[8] Surh YJ, Hurh YJ, Kang JY , et al. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia(HL-60) cells[J]. Cancer Lett, 1999,140(1-2):1-10
doi: 10.1016/S0304-3835(99)00039-7
[9] Sun CY, Hu Y, Guo T , et al. Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity[J]. Acta Pharmacol Sin, 2006,27(11):1447-1452
doi: 10.1111/aphs.2006.27.issue-11
[10] Woo JH, Lim JH, Kim YH , et al. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction[J]. Oncogene, 2004,23(10):1845-1853
doi: 10.1038/sj.onc.1207307
[11] Huhtala P, Chow LT, Tryggvason K . Structure of the human type Ⅳ collagenase gene[J]. J Biol Chem, 1990,265(19):11077-11082
doi: 10.1111/j.1432-1033.1990.tb15618.x pmid: 2162831
[12] Li YT, Shen F, Liu BH , et al. Resveratrol inhibits matrix metalloproteinase-9 transcription in U937 cells[J]. Acta Pharmacol Sin, 2003,24(11):1167-1171
doi: 10.1016/S0300-483X(03)00336-6 pmid: 14627504
[13] Ge H, Zhang JF, Guo BS , et al. Resveratrol inhibits expression of EMMPRIN from macrophages[J]. Yao Xue Xue Bao, 2006,41(7):625-630
葛恒, 张俊峰, 郭炳诗 . 白藜芦醇抑制巨噬细胞细胞外基质金属蛋白酶诱导物的表达[J]. 药学学报, 2006,41(6):625-630
[1] Fang Quan, Shao-qiang Zhang, Yan-xia Bai, Xiao-bao Yao, Hong-hui Li, LiangYu, Cheng-en Pan. Resveratrol increases sensitivity of CNE2 cells to chemotherapeutic drugs under hypoxia. Journal of Chinese Integrative Medicine, 2009, 7(10): 952-957.
[2] Huo-jun Zhang, Ji-jin Yang, Wei-xing Wang, Xu Jiang, Yan-jun Mao, Chao-ai Yang, Ji-xiang Guo. Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy. Journal of Chinese Integrative Medicine, 2008, 6(9): 907-910.
[3] Zhi-qiang Pan, Zhao-qin Fang, Wen-li Lu, Chao Liang, Zhong-hua Wu, Xiao-mei Liu, Li Hou, Hui Zhang, Shao-yuan Zhuo, Ming-juan Liao, Bi-feng Gao. Differentially expressed genes in adrenal gland of H22 liver cancer mice with different syndromes and in different stages. Journal of Chinese Integrative Medicine, 2008, 6(8): 843-851.
[4] Zhi-jun Dai, Xi-jing Wang, Qian Xue, Zong-zheng Ji, Xiao-xu Liu, Hua-feng Kang, Hai-tao Guan, Xiao-bin Ma, Hong-tao Ren. Effects of Scutellaria Barbata drug-containing serum on apoptosis and mitochondrial transmembrane potential of hepatoma H22 cells. Journal of Chinese Integrative Medicine, 2008, 6(8): 821-826.
[5] Zhi-jun Dai, Xi-jing Wang, Zong-zheng Ji, Zong-fang Li, Wei Tang, Hua-feng Kang, Xiao-bin Ma, Lei Liu. Scutellaria barbata extract enhances efficacy and reduces toxicity of chemotherapy in hepatoma H22-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(7): 720-724.
[6] Hong-yun Chen, Zhe Chen. Transcatheter arterial chemoembolization combined with other therapies for the treatment of primary hepatic carcinoma: a review. Journal of Chinese Integrative Medicine, 2008, 6(4): 422-426.
[7] Zhao-cheng Zhu, Qing-bo Lang, Zhe Chen, Dong-tao Li, Chang-quan Ling. Evaluation of Chinese version of the Functional Assessment of Cancer Therapy-Hepatobiliary questionnaire. Journal of Chinese Integrative Medicine, 2008, 6(4): 341-345.
[8] Zhen Sun, Yong-hua Su, Xiao-qiang Yue. Professor Ling Changquan's experience in treating primary liver cancer: an analysis of herbal medication. Journal of Chinese Integrative Medicine, 2008, 6(12): 1221-1225.
[9] Tan Li, Wei Wang, Tong Li. Antileukemic mechanism of resveratrol in vitro and in mice bearing L1210-tumor. Journal of Chinese Integrative Medicine, 2008, 6(12): 1267-1274.
[10] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82.
[11] Chen Zhang, Bai Li, Shu-qin Lu, Yong Li, Yong-hua Su, Chang-quan Ling. Effects of melittin on expressions of mitochondria membrane protein 7A6, cell apoptosis-related gene products Fas and Fas Ligand in hepatocarcinoma cells. Journal of Chinese Integrative Medicine, 2007, 5(5): 559-563.
[12] Ju-yong Wang, Zhen-ye Xu. Effects of NK-104 on apoptosis and caspase-3 activity in hepatocellular carcinoma cells. Journal of Chinese Integrative Medicine, 2007, 5(3): 298-301.
[13] Wei Gu, Ke-qi Han, Yong-hua Su, Xue-qiang Huang, Chang-quan Ling. Inhibition action of bufalin on human transplanted hepatocellular tumor and its effects on expressions of Bcl-2 and Bax proteins in nude mice. Journal of Chinese Integrative Medicine, 2007, 5(2): 155-159.
[14] Xiao-yan Mu, Ai-guang Zhao. Progress in research of traditional Chinese medicine in inducing differentiation of human hepatoma cells. Journal of Chinese Integrative Medicine, 2007, 5(1): 92-96.
[15] Ying-lu Feng, Chang-quan Ling, De-zeng Zhu, Chao-qin Yu, Zhe Chen, Bai Li. Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: A randomized, controlled and double-blinded prospective trial. Journal of Chinese Integrative Medicine, 2005, 3(2): 99-102.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239
[an error occurred while processing this directive]